Glaucoma ocular hypertension
Conditions
Interventions
1. Use of the Travalert dosing aid
2. Use of the Travalert with the Eyot drop guider
3. Use of the Travalert together with patient education
4. Use of the Travalert and Eyot together with patient educ
Sponsors
Alcon Laboratories
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Diagnosis glaucoma or ocular hypertension Treatment with travoprost or travoprost/timolol
Exclusion criteria
Exclusion criteria: High risk of side effects expected from travoprost or travoprost/timolol Absolute inability to administer eye drops Difficulty in reading or speaking Dutch
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint is the intraocular pressure measured at the ophthalmologists office. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are the registration of adherence by the Travalert, the weight of the medication bottles, patient satisfaction and refill compliance in the next three years. | — |
Countries
Netherlands
Outcome results
None listed